tiprankstipranks
Trending News
More News >
Bristol-Myers Squibb Company (DE:BRM)
NYSE:BRM
Germany Market

Bristol-Myers Squibb (BRM) Technical Analysis

Compare
18 Followers

Summary of all the Indicators

Overall Consensus
Buy
15Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Bristol-Myers Squibb Company’s (BRM) Moving Averages Convergence Divergence (MACD) indicator is 1.25, suggesting Bristol-Myers Squibb Company is a Sell.
Bristol-Myers Squibb Company’s (BRM) 20-Day exponential moving average is 48.07, while Bristol-Myers Squibb Company’s (BRM) share price is €51.59, making it a Buy.
Bristol-Myers Squibb Company’s (BRM) 50-Day exponential moving average is 46.02, while Bristol-Myers Squibb Company’s (BRM) share price is €51.59, making it a Buy.

Bristol-Myers Squibb (BRM) Pivot Points

Feb 11, 2026, 11:09 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
48.26
49.15
50.64
51.53
53.02
53.91
55.40
Fibonacci
49.15
50.06
50.62
51.53
52.44
53.00
53.91
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Bristol-Myers Squibb (BRM) Moving Averages

Feb 11, 2026, 11:09 PM
Period
Simple
Exponential
MA5
50.23Buy
50.41Buy
MA10
48.32Buy
49.16Buy
MA20
47.77Buy
48.07Buy
MA50
46.04Buy
46.02Buy
MA100
42.32Buy
44.10Buy
MA200
41.03Buy
43.73Buy
Bristol-Myers Squibb Company’s (BRM) 10-Day exponential moving average is 49.16, while Bristol-Myers Squibb Company’s (BRM) share price is €51.59, making it a Buy.
Bristol-Myers Squibb Company’s (BRM) 100-Day exponential moving average is 44.10, while Bristol-Myers Squibb Company’s (BRM) share price is €51.59, making it a Buy.
Bristol-Myers Squibb Company’s (BRM) stock price is €51.59 and Bristol-Myers Squibb Company’s (BRM) 50-day simple moving average is 46.04, creating a Buy signal.
Bristol-Myers Squibb Company’s (BRM) stock price is €51.59 and Bristol-Myers Squibb Company’s (BRM) 100-day simple moving average is 42.32, creating a Buy signal.
Bristol-Myers Squibb Company’s (BRM) stock price is €51.59 and Bristol-Myers Squibb Company’s (BRM) 200-day simple moving average is 41.03, creating a Buy signal.

Bristol-Myers Squibb (BRM) Technical Indicators

Feb 11, 2026, 11:09 PM
Name
Value
Implied Action
RSI (14)
72.09
Sell
STOCH (9,6)
93.50
Sell
STOCHRSI (14)
93.50
Sell
MACD (12,26)
1.25
Sell
ADX (14)
26.31
Neutral
Williams %R
-11.62
Sell
CCI (14)
192.63
Sell
ATR (14)
1.19
-
Ultimate Oscillator
80.24
Buy
ROC
10.64
Buy
Bristol-Myers Squibb Company’s (BRM) Relative Strength Index (RSI) is 72.09, creating a Sell signal.
Bristol-Myers Squibb Company’s (BRM) Trend Strength Indicator (ADX) is 26.31, creating a Neutral signal.
Bristol-Myers Squibb Company’s (BRM) Commodity Channel Index (CCI) is 192.63, creating a Sell signal.
Bristol-Myers Squibb Company’s (BRM) Price Rate of Change (ROC) is 10.64, creating a Buy signal.

FAQ

Is BRM a Buy, Hold, or Sell?
Based on BRM’s technical indicators, BRM is a Buy.
    What is BRM’s RSI (14)?
    BRM’s RSI (14) is 72.09, which suggests BRM is a Sell.
      What is BRM’s MACD?
      BRM’s MACD is 1.25, which suggests BRM is a Sell.
        What is BRM’s 5-day moving average?
        BRM’s 5-day moving average is 50.23, which suggests BRM is a Buy.
          What is BRM’s 20-day moving average?
          BRM 20-day moving average is 47.77, which suggests BRM is a Buy.
            What is BRM’s 50-day moving average?
            BRM’s 50-day moving average is 46.04, which suggests BRM is a Buy.
              What is BRM’s 200-day moving average?
              BRM’s 200-day moving average is 41.03, which suggests BRM is a Buy.
                What is BRM’s Williams % R (14)?
                BRM’s Williams % R (14) is -11.62, which suggests BRM is a Sell.
                  What is BRM’s CCI (14)?
                  BRM’s CCI (14) is 192.63, which suggests BRM is a Sell.
                    What is the share price of Bristol-Myers Squibb Company?